Walt Ling

Walt Ling is an experienced executive currently serving as the Chief Executive Officer of ACT Genomics since June 2023. Prior to this role, Walt held significant positions such as Vice President and Managing Director of APAC at Oxford Immunotec from 2019 to 2023, and Vice President for Asia-Pacific at Leica Biosystems from 2015 to 2018. Walt also worked at Teleflex from 2010 to 2015 as Managing Director and General Manager for Korea, India, Southeast Asia, and Australia. Walt holds an MBA in Marketing and Finance from Northwestern University's Kellogg School of Management and a BBA in Marketing from The University of Texas at Austin.